Join to View Full Profile
8333 Naab RdSte 250Indianapolis, IN 46260
Phone+1 317-338-5100
Fax+1 317-338-5101
Dr. Mastrodicasa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Mastrodicasa is a pulmonologist based in Indianapolis, IN, with a subspecialty in critical care medicine. He completed his internal medicine residency and served as chief resident at The MetroHealth System/Case Western Reserve University, followed by a residency in pulmonary disease and critical care medicine at the University of Cincinnati Medical Center. He graduated from St. George's University School of Medicine in 2009. Dr. Mastrodicasa has experience with asthma and has published a review on long-acting muscarinic antagonists for chronic obstructive pulmonary disease, which has been cited 12 times.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Pulmonary Disease and Critical Care Medicine, 2017
The MetroHealth System/Case Western Reserve UniversityChief Residency, Internal Medicine, 2013 - 2014- The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 2010 - 2013
St. George's University School of MedicineClass of 2009
Certifications & Licensure
IN State Medical License 2017 - 2025
OH State Medical License 2010 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 12 citationsLong acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugsMark A Mastrodicasa, Christopher A. Droege, Aaron M. Mulhall, Neil Ernst, Ralph J. Panos
Expert Opinion on Investigational Drugs. 2017-01-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
